Countries covered: India
India is an increasingly attractive destination for R&D activities in the pharmaceutical and biotechnology industry. Being an emerging market, companies face a number of unique hurdles before entering this lucrative region.
The report provides an overview of the Indian pharma and biotech market, and answers the following key questions:
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How can companies engage with India for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Readers will gain an analysis of the regulatory environment, insights into collaborative opportunities and detailed information on the key companies, clusters and government initiatives.
This report is a valuable resource for use by all those developing company strategy and direction in this key emerging market.
'India: Pharmaceutical and biotechnology opportunities' is based on the December 2004 report 'India: The emerging R&D collaborative opportunity'. The new report includes additional sections on the Indian Patents Act 2005, the Indian pharmaceutical policy, an overview of Department of Biotechnology initiatives, including details of biotechnology parks, and an all-new set of profiles on life science research institutes.
The profiles section of 'India: Pharmaceutical and biotechnology opportunities' contains updated profiles and contact details on key companies.
Reasons to purchase (USPs and key questions answered)
This report will provide the reader with an insight into the Indian pharmaceutical market and the emerging R&D collaborative opportunities on offer.
The report answers the following key questions about the Indian R&D collaborative opportunity:
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How to engage with Indian companies for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Report scope
Scope of report:
- An overview of the Indian pharmaceutical industry
- Key players in the Indian pharmaceutical market
- An analysis of the regulatory environment and its implications for R&D
- Collaborative R&D opportunities in India
- Engagement models for licensing and purchasing innovation and for contracting research services
- Approaches to collaboration in NCE/NDDS, biopharma, drug discovery, biotechnology, bioinformatics, and clinical research
- Profiles of leading R&D companies—NCE/DDS, bioinformatics, biopharma, drug discovery, clinical research
- Profiles of life science research institutes
- Regional Government initiatives
|
Additional InformationWho should buy the report
This report is suitable to individuals responsible for and interested in:
- Board and executive management
- Business development
- Licensing/partnering
- Deal making
- Business strategy
- Marketing and promotion
- Distribution and manufacturing (including contract services)
- Contract R&D services
- Collaborative R&D opportunities
Companies analyzed/mentioned
Dr Reddy’s Laboratories
Glenmark Pharmaceuticals
Lupin
Nicholas Piramal India
Ranbaxy Laboratories
Wockhardt
Zydus Cadila
Avestha Gengraine Technologies
Jubilant Biosys
Molecular Connections
Ocimum Biosolutions
Strand Genomics
SysArris Software
Bigtec Private
LabVantage Solutions
Aurigene Discovery Technologies
Syngene
Reliance Research and Development Services
Reliance Life Sciences
Clinigene International
iGATE Clinical Research
SIRO Clinpharm
Wellquest CRO
Reliance Clinical Research Services
ClinTec
Quintiles India
- 1. Global collaborative R&D trends
- 1.1. Falling R&D productivity
- 1.1.1. Strategies adopted by global pharmaceutical companies to counter falling R&D productivity
- 1.2. Look East trend
- 2. The Indian pharmaceutical industry
- 2.1. Overview
- 2.2. Market assessment
- 2.3. Key players in the Indian pharmaceutical market
- 3. An analysis of the regulatory environment and its implications for R&D
- 3.1. Regulation in the Indian pharmaceutical industry: A historical perspective
- 3.2. The changing regulatory environment in India-Advantage R&D
- 3.3. An analysis of India's changing regulatory framework
- 3.3.1. Indian Patent Act, 1970
- 3.3.2. Patents Amendment Act, 2002
- 3.3.3. The Patents Amendment Ordinance, 2004
- 3.3.4. Indian Patents (Amendment) Act, 2005
- 3.3.5. New pharmaceutical policy (2006): Focus on R&D
- 3.3.5.1. Definitions of R&D
- 3.3.5.2. Technology upgrade funding
- 3.4. Response of MNCs to the changing regulatory environment
- 3.5. Implications for the Indian pharmaceutical industry
- 3.5.1. Collaborative and contract research and development
- 3.5.2. In- and out-licensing innovations
- 4. Collaborative R&D opportunities in India
- 4.1. Overview
- 4.2. Engagement models for licensing/purchasing innovation
- 4.3. Engagement models for contracting research services
- 4.4. NCE and NDDS research
- 4.5. Biopharma & drug discovery
- 4.5.1. Indian biopharma industry
- 4.5.1.1. Market size estimates: Indian biopharma industry
- 4.5.1.2. Indian biopharma industry: Vaccines segment
- 4.5.1.3. Indian biopharma industry: Therapeutics segment
- 4.5.1.4. Indian biopharma industry: Diagnostics segment
- 4.5.2. Drug discovery services
- 4.5.3. Indian biotechnology: Initiatives by the Department of Biotechnology
- 4.5.3.1. National Biotechnology Development Strategy
- 4.5.3.1.1. Fiscal and trade policy initiatives
- 4.5.3.1.2. Financial incentives
- 4.5.3.1.3. Biotechnology parks
- 4.5.3.1.4. Regulatory mechanisms
- 4.5.3.1.5. Create a cadre of resource persons
- 4.5.3.1.6. Empowering a judiciary
- 4.5.3.1.7. Industrial mechanisms for strengthening public trust
- 4.5.3.1.8. Single window
- 4.5.3.1.9. Innovation
- 4.5.3.1.10. Strengthening technology transfer capacity
- 4.5.3.1.11 National Task Force on Education & Training
- 4.5.3.1.12 Needs assessment
- 4.5.3.2. Stem cell research policy
- 4.5.4. Major recent developments in biotechnology
- 4.6. Bioinformatics.
- 4.6.1. Market size estimates of Indian bioinformatics industry
- 4.6.2. Bioinformatics companies in India
- 4.6.3. Bioinformatics policy of India
- 4.6.4. Major recent developments in bioinformatics
- 4.7. Clinical research
- 4.7.1. Market size estimates of the Indian clinical research industry
- 4.7.2. Clinical trials: MNC focus on India
- 4.7.3. Government initiatives to boost clinical research in India
- 4.7.4. Outsourcing clinical data management to India
- 4.7.4.1. CROs
- 4.7.4.2. IT-pharmaceutical ventures
- 4.7.4.3. Other IT/ITES companies' bio-initiatives
- 5. Conclusions
- 6. Company profiles
- 6.1. NCE/NDDS
- 6.1.1. Dr Reddy's Laboratories Limited
- 6.1.1.1. Overview
- 6.1.1.2. R&D focus
- 6.1.1.3. Financials
- 6.1.1.4. Contact information
- 6.1.2. Glenmark Pharmaceuticals Ltd
- 6.1.2.1. Overview
- 6.1.2.2. R&D focus
- 6.1.2.3. Financials
- 6.1.2.4. Contact information
- 6.1.3. Lupin Limited
- 6.1.3.1. Overview
- 6.1.3.2. R&D focus
- 6.1.3.3. Financials
- 6.1.3.4. Contact information
- 6.1.4. Nicholas Piramal India Limited
- 6.1.4.1. Overview
- 6.1.4.2. R&D focus
- 6.1.4.3. R&D collaborations
- 6.1.4.4. Financials
- 6.1.4.5. Contact information
- 6.1.5. Ranbaxy Laboratories Limited
- 6.1.5.1. Overview
- 6.1.5.2. R&D focus
- 6.1.5.3. Financials
- 6.1.5.4. Contact information
- 6.1.6.Wockhardt Limited
- 6.1.6.1. Overview
- 6.1.6.2. R&D focus
- 6.1.6.3. Financials
- 6.1.6.4. Contact information
- 6.1.7. Zydus Cadila
- 6.1.7.1. Overview
- 6.1.7.2. R&D focus
- 6.1.7.3. Financials
- 6.1.7.4. Contact information
- 6.2. Bioinformatics
- 6.2.1. Avestha Gengraine Technologies Pvt. Ltd.
- 6.2.1.1. Overview
- 6.2.1.2. Products and services
- 6.2.1.3. Customer deals
- 6.2.1.4. Contact information
- 6.2.2. Jubilant Biosys Ltd
- 6.2.2.1. Overview
- 6.2.2.2. Products and services
- 6.2.2.3. Customer deals
- 6.2.2.4. Contact information
- 6.2.3. Molecular Connections Private Limited
- 6.2.3.1. Overview
- 6.2.3.2. Products and services
- 6.2.3.3. Customer deals
- 6.2.3.4. Contact information
- 6.2.4. Ocimum Biosolutions Ltd
- 6.2.4.1. Overview
- 6.2.4.2. Products and services
- 6.2.4.3. Customer deals
- 6.2.4.4. Contact information
- 6.2.5. Strand Genomics
- 6.2.5.1. Overview
- 6.2.5.2. Products and services
- 6.2.5.3. Customer deals
- 6.2.5.4. Contact information
- 6.2.6. SysArris Software Pvt. Ltd
- 6.2.6.1. Overview
- 6.2.6.2. Products and services
- 6.2.6.3. Customer deals
- 6.2.6.4. Contact information
- 6.2.7. Bigtec Private Ltd.
- 6.2.7.1. Overview
- 6.2.7.2. Products and services
- 6.2.7.3. Customer deals
- 6.2.7.4. Contact information
- 6.2.8. LabVantage Solutions Private Ltd
- 6.2.8.1. Overview
- 6.2.8.2. Products and services
- 6.2.8.3. Customer deals
- 6.2.8.4. Contact information
- 6.3. Biopharma & drug discovery services
- 6.3.1. Aurigene Discovery Technologies Limited
- 6.3.1.1. Overview
- 6.3.1.2. Products and services
- 6.3.1.3. Contact information
- 6.3.2. Syngene International Private Limited
- 6.3.2.1. Overview
- 6.3.2.2. Products and services
- 6.3.2.3. Customer deals
- 6.3.2.4. Contact information
- 6.3.3. Reliance Research and Development Services
- 6.3.3.1. Overview
- 6.3.3.2. Products and services
- 6.3.3.3. Contact information
- 6.3.4. Reliance Life Sciences
- 6.3.4.1. Overview
- 6.3.4.2. Products and services
- 6.3.4.3. Contact information
- 6.4. Clinical Research
- 6.4.1. Clinigene International Private Limited
- 6.4.1.1. Overview
- 6.4.1.2. Products and services
- 6.4.1.3. Contact information
- 6.4.2. iGATE Clinical Research International
- 6.4.2.1. Overview
- 6.4.2.2. Products and services
- 6.4.2.3. Contact information
- 6.4.3. SIRO Clinpharm Pvt. Ltd.
- 6.4.3.1. Overview
- 6.4.3.2. Products and services
- 6.4.3.3. Contact information
- 6.4.4. Wellquest CRO
- 6.4.4.1. Overview
- 6.4.4.2. Products and services
- 6.4.4.3. Contact information
- 6.4.5. Reliance Clinical Research Services
- 6.4.5.1. Overview
- 6.4.5.2. Products and services
- 6.4.5.3. Contact information
- 6.4.6. ClinTec International
- 6.4.6.1. Overview
- 6.4.6.2. Products and services
- 6.4.6.3. Contact information
- 6.4.7. Quintiles India
- 6.4.7.1. Overview
- 6.4.7.2. Products and services
- 6.4.7.3. Contact information
- 7. Life science research institute profiles
- 7.1. Central Drug Research Institute
- 7.1.1. Overview
- 7.1.2. R&D focus
- 7.1.3. R&D expertise and technical facilities
- 7.1.4. Collaborative opportunities
- 7.1.5. Products and technologies developed
- 7.1.5.1. Technologies developed
- 7.1.6. Pharmaceutical and biotechnology opportunities
- 7.1.7. Contact information
- 7.2. Indian Institute of Chemical Technology
- 7.2.1. Overview
- 7.2.2. R&D focus
- 7.2.3. R&D expertise and technical facilities
- 7.2.4. Collaborative opportunities
- 7.2.5. Products and technologies developed
- 7.2.6. Key collaborations
- 7.2.7. Contact information
- 7.3. National Chemical Laboratory
- 7.3.1. Overview
- 7.3.2. R&D focus
- 7.3.3. R&D expertise and technical facilities
- 7.3.4. Collaborative opportunities
- 7.3.5. Key collaborations
- 7.3.6. Contact information
- 7.4. Center for Cellular and Molecular Biology
- 7.4.1. Overview
- 7.4.2. R&D focus
- 7.4.3. R&D expertise and technical facilities
- 7.4.4. Collaborative opportunities
- 7.4.5. Products and technologies developed
- 7.4.6. Key collaborations
- 7.4.7. Contact information
- 7.5. Institute of Microbial Technology
- 7.5.1. Overview
- 7.5.2. R&D focus
- 7.5.3. R&D expertise and technical facilities
- 7.5.4. Collaborative opportunities
- 7.5.5. Products and technologies developed
- 7.5.6. Key collaborations
- 7.5.7. Contact information
- 8. Indian biotechnology: Regional Government initiatives
- 8.1. Orissa State (Eastern India)
- 8.1.1. Orissa biotechnology parks
- 8.2. West Bengal State (Eastern India)
- 8.3. Gujarat State (Western India)
- 8.3.1. International Pharma & Biotech Park, Ahmedabad
- 8.3.1.1. Contact information
- 8.3.2. Biotechnology park, Vadodra
- 8.4. Maharashtra State (Western India)
- 8.4.1. International Biotech Park, Pune
- 8.4.1.1. Contact information
- 8.4.2. Jalna Agri Biotech Park, Jalna
- 8.5. Punjab State (Northern India)
- 8.5.1. Punjab Biotech Park, Derabassi, near Chandigarh
- 8.5.1.1. Contact information
- 8.5.2. Other initiatives
- 8.6. Haryana State (Northern India)
- 8.7. Himachal Pradesh State (Northern India)
- 8.7.1. Biotech parks
- 8.8. Rajasthan State (Northern India)
- 8.8.1. Biotechnology park at Sitapura-Jaipur
- 8.8.1.1. Contact information
- 8.8.2. Biotechnology park at Boranada, Jodhpur
- 8.8.3. Biotechnology park at Bhiwadi, Alwar
- 8.9. Uttar Pradesh State (Northern India
- 8.9.1. Lucknow biotechnology park, Lucknow
- 8.9.1.1. Contact information
- 8.9.2. Biotech City, NOIDA
- 8.10. Uttaranchal State (Northern India
- 8.10.1. Biotech park, Pantnagar
- 8.11. Madhya Pradesh State (Central India
- 8.12. Karnataka State (Southern India
- 8.12.1. Bangalore biotechnology park (Bangalore Helix)
- 8.12.1.1. Contact information
- 8.13. Kerala State (Southern India)
- 8.13.1. KINFRA biotech park, Kalamassery
- 8.13.1.1. Contact information
- 8.13.2. KINFRA biotechnology park, Trivandrum
- 8.14. Andhra Pradesh State (Southern India)
- 8.14.1. ICICI Knowledge Park, Turkapally
- 8.14.2. Shapoorji Pallonji Biotech Park, Genome Valley, Hyderabad
- 8.14.2.1. Contact information
- 8.15. Tamil Nadu State (Southern India)
- 8.15.1. TICEL Bio Park
- 8.15.1.1. Contact information
- 8.15.2. Mahindra Industrial Park, Mahindra City
- 8.15.1.2. Contact information
- 9. Appendices
- 9.1. References
- 9.2. References
- 9.3. Abbreviations
- 9.4. Glossary
- 9.5. Author biographies
- 9.5.1. Siraj Dhanani
- 9.5.2. Amit Sadana
- 9.5.3. Ashish Malik
- 9.5.4. PharmARC
More India Research & Development Reports
Oncology Pharmaceuticals Market in India 2012 by
Netscribes (India) Pvt. Ltd.
Oncology pharmaceuticals market in India, a leading segment of the overall pharmaceuticals market is the fourth largest in volume and eighth largest in value in ...
Cardiovascular Pharmaceuticals Market in India 2012 by
Netscribes (India) Pvt. Ltd.
Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the ...
Clinical Trials Market in India 2012 by
Netscribes (India) Pvt. Ltd.
The Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract ...
Clinical Trials in India by
Cygnus Business Consulting and Research
Clinical Trial industry in India touched US$400 million in 2010 and is expected to touch US$1.09 billion by 2014.
Clinical Trials market in India ...
Special Report: Opportunities in Emerging Markets—Developing Asia by
Decision Resources
Asia boasts 6 of the 20 largest economies in the world: China, Japan, India, Russia, Australia, and Indonesia. The countries of developing Asia are all ...
See all reports like this >>
More India Reports
D&B Country RiskLine Report: India by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: India by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report India January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Share this report
Other tasks Related Markets Research & Development Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
